Clinical Trials Logo

Clinical Trial Summary

Treatment with the immunosuppressive drug mycophenolate mofetil (MMF) may result in gastrointestinal (GI) complications in some patients. This study will 1) determine the proportion of patients with autoimmune diseases who are experiencing any GI complaints under MMF-based immunosuppressive treatment and 2) assess if a switch from MMF to enteric-coated mycophenolate sodium (EC-MPS) results in improved GI and/or health-related quality of life outcomes.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00351377
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date June 2006
Completion date June 2009

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01934764 - Identification of Correlations Between Reaction to Biotine and Autoimmune Diseases N/A
Recruiting NCT01665196 - 18F-FDG PET/CT for IgG4-Related Disease Early Phase 1
Withdrawn NCT02948855 - Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Completed NCT01815996 - Identify Clinical Conditions That Increase Circulating DNA Levels
Completed NCT02434458 - Sudoscan in Patients With Autoimmune Disorders N/A
Completed NCT02263703 - Immunogenicity of HPV Vaccine in Immunosuppressed Children Phase 3
Completed NCT00013689 - Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome Phase 1
Completed NCT00340600 - Continuation of Follow-up of DES-Exposed Cohorts
Not yet recruiting NCT05894707 - Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers Phase 1
Completed NCT02647866 - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Phase 2
Active, not recruiting NCT00716066 - Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases Phase 2
Completed NCT00114530 - Scleroderma: Cyclophosphamide or Transplantation Phase 2/Phase 3
Completed NCT00001630 - Treatment of Autoimmune Thrombocytopenia (AITP) Phase 1
Completed NCT00372177 - The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis Phase 1/Phase 2
Completed NCT00065390 - Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome Phase 1
Completed NCT00001658 - Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections Phase 4
Recruiting NCT03816345 - Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Phase 1
Completed NCT00001306 - Steroid Therapy in Autoimmune Premature Ovarian Failure N/A
Recruiting NCT03715699 - Leflunomide Treatment for IgG4-RD N/A
Completed NCT02925351 - Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases Early Phase 1